Albireo Appoints Dr. Paresh N. Soni as Chief Medical Officer

BOSTON, Sept. 08, 2016 -- (Healthcare Sales & Marketing Network) -- Albireo Limited, a clinical-stage company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver... Biopharmaceuticals, Gastroenterology, Personnel Albireo, bile acid modulator
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news